Tirzepatide Lyophilized High Purity 99% Peptide Powder TR 10mg 15mg 20mg 30mg kowace vial don sukarin jini / ciwon sukari

Tirzepatide wani labari ne na glucose mai dogaro da insulinotropic polypeptide / glucagon-like peptide 1 (GLP-1) agonist mai karɓa wanda aka amince dashi a cikin Amurka azaman haɗin kai ga abinci da motsa jiki don haɓaka sarrafa glycemic a cikin manya da nau'in ciwon sukari na 2 kuma a ƙarƙashin bincike don amfani a cikin sarrafa nauyi na yau da kullun, manyan cututtukan zuciya da jijiyoyin jini da sarrafa wasu yanayi, gami da gazawar zuciya da rashin ƙarfi na kiba. steatohepatitis ba barasa. An tsara shirin gwaji na asibiti na Phase 3 SURPASS 1-5 don tantance inganci da amincin allurar tirzepatide sau ɗaya-mako-mako (5, 10 da 15 MG), azaman maganin monotherapy ko haɗin gwiwa, a cikin ɗimbin mutane masu fama da ciwon sukari na 2. Yin amfani da tirzepatide a cikin nazarin asibiti yana da alaƙa da raguwar raguwar haemoglobin glycated (-1.87 zuwa -2.59%, -20 zuwa -28 mmol / mol) da nauyin jiki (-6.2 zuwa -12.9 kg), da kuma raguwa a cikin sigogi da aka danganta da haɓakar haɗarin cardiometabolic kamar hawan jini, visceral visceral. An yi haƙuri da Tirzepatide da kyau, tare da ƙarancin haɗarin hypoglycemic lokacin amfani da shi ba tare da insulin ko ɓoyewar insulin ba kuma ya nuna kwatankwacin bayanin martabar aminci ga rukunin agonist mai karɓa na GLP-1. Saboda haka, shaidu daga waɗannan gwaje-gwaje na asibiti sun nuna cewa tirzepatide yana ba da sabuwar dama don rage yawan haemoglobin glycated da nauyin jiki a cikin manya masu ciwon sukari na 2.